Precigen Valuation

PGEN Stock  USD 1.78  0.02  1.11%   
Based on Macroaxis valuation methodology, the company appears to be undervalued. Precigen holds a recent Real Value of $2.62 per share. The prevailing price of the company is $1.78. Our model determines the value of Precigen from analyzing the company fundamentals such as Current Valuation of 501.62 M, return on equity of -1.37, and Shares Owned By Insiders of 9.92 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Precigen's valuation include:
Price Book
9.4716
Enterprise Value
501.6 M
Enterprise Value Ebitda
(3.31)
Price Sales
133.0215
Forward PE
9.1408
Undervalued
Today
1.78
Please note that Precigen's price fluctuation is dangerous at this time. Calculation of the real value of Precigen is based on 3 months time horizon. Increasing Precigen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Precigen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Precigen Stock. However, Precigen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.78 Real  2.62 Target  5.33 Hype  1.89
The intrinsic value of Precigen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Precigen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.62
Real Value
9.46
Upside
Estimating the potential upside or downside of Precigen helps investors to forecast how Precigen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Precigen more accurately as focusing exclusively on Precigen's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.12-0.11-0.11
Details
Hype
Prediction
LowEstimatedHigh
0.091.898.73
Details
5 Analysts
Consensus
LowTarget PriceHigh
4.855.335.92
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Precigen's intrinsic value based on its ongoing forecasts of Precigen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Precigen's closest peers.

Precigen Cash

6.48 Million

Precigen Valuation Trend

Knowing Precigen's actual value is paramount for traders when making sound investment determinations. Using both Precigen's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Precigen Total Value Analysis

Precigen is at this time forecasted to have valuation of 501.62 M with market capitalization of 527.16 M, debt of 7.1 M, and cash on hands of 115.3 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Precigen fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
501.62 M
527.16 M
7.1 M
115.3 M

Precigen Investor Information

About 66.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.54. Precigen had not issued any dividends in recent years. Based on the analysis of Precigen's profitability, liquidity, and operating efficiency, Precigen may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.

Precigen Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Precigen has an asset utilization ratio of 4.12 percent. This suggests that the Company is making $0.0412 for each dollar of assets. An increasing asset utilization means that Precigen is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

Precigen Ownership Allocation

Precigen owns a total of 292.87 Million outstanding shares. Over half of Precigen's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Precigen Profitability Analysis

The company reported the previous year's revenue of 6.22 M. Net Loss for the year was (95.9 M) with loss before overhead, payroll, taxes, and interest of (49.11 M).

About Precigen Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Precigen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Precigen based exclusively on its fundamental and basic technical indicators. By analyzing Precigen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Precigen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Precigen. We calculate exposure to Precigen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Precigen's related companies.
Last ReportedProjected for Next Year
Gross Profit121.9 K115.8 K
Pretax Profit Margin(17.80)(16.91)
Operating Profit Margin(16.43)(15.61)
Net Loss(17.72)(16.83)
Gross Profit Margin 0.02  0.01 

Precigen Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding244.5 M
Forward Price Earnings9.1408

Precigen Current Valuation Indicators

Precigen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Precigen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Precigen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Precigen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Precigen's worth.
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.43)
Return On Equity
(1.37)
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.